BARBARA GREEN: Open Payments
NPI 1790306637 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 30 payments from 9 companies in 2025. Trend: 2023 $141 · 2024 $374 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $395 |
| AstraZeneca Pharmaceuticals LP | 5 | $155 |
| GlaxoSmithKline, LLC. | 5 | $86 |
| Boston Scientific Corporation | 3 | $59 |
| PFIZER INC. | 2 | $54 |
| Lilly USA, LLC | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Wegovy, Ozempic, FARXIGA, TRELEGY ELLIPTA, FARAPULSE, ELIQUIS, AIRSUPRA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
